Phase 2 Stomach Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People of any gender are welcome to participate
- You must be 14 years old or older
- You must have a confirmed diagnosis of one of the following: a specific type of leukemia called ETP-like leukemia, a T-cell leukemia (T-ALL) that also has certain genetic changes linked to a different type of blood cancer, or a mixed leukemia that has features of both T-cell and myeloid (a type of blood cell) leukemia — (confirm with trial site which category applies to you)
- You must be newly diagnosed and not yet had main treatment for your leukemia, though some very limited prior treatments are allowed (confirm with trial site)
- Doctors expect you to live for at least 3 months or more
- Your liver, kidneys, and heart must be functioning well enough to meet specific medical thresholds (confirm with trial site)
- You must be willing and able to understand the study and sign a consent form agreeing to take part
Who may not be able to join:
- People whose leukemia involves certain specific genetic abnormalities known as t(8;21), t(15;17), or inv(16)/t(16;16) cannot join
- People who have had a serious allergic reaction to the study drugs or very similar medications in the past
- People who currently have an active infection that is not under control
- People who are currently experiencing active bleeding
- People who have had a blood clot, embolism, or bleeding in the brain within the past year
- Women who are pregnant, breastfeeding, or who are able to become pregnant but are unwilling to use contraception during the trial
- People with a history of drug addiction or heavy ongoing alcohol use that could affect the trial results
- People with a mental health condition or other situation that would prevent them from giving consent or following the trial requirements
- Anyone that the trial doctor feels would not be suitable for the trial for any other reason
⚠️ Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Yue-jun Liu, The First Affiliated Hospital of Soochow University
Phone: 008613915535177
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Overall response rate (ORR) after two treatment cycles of induction therapy
Can't join this trial?
Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.